Sony DADC and Maven Biotechnologies, LLC to Develop Smart Consumables for Novel Label-Free Detection
SALZBURG, Austria & MONROVIA, Calif.--(BUSINESS WIRE)--Sony DADC BioSciences and Maven Biotechnologies today announced a collaboration to develop and manufacture smart consumables for Maven’s LFIRE™ detection platform.
LFIRE™ stands for Label-Free Internal Reflection Ellipsometry. It is a flexible and cost-effective, real-time imaging technology for performing cell-based assays and multiplexed biomarker detection. In 2010, the National Institute of Health (NIH) awarded Maven a $1.96 million grant to commercialize the technology.
LFIRE™ stands for Label-Free Internal Reflection Ellipsometry. It is a flexible and cost-effective, real-time imaging technology for performing cell-based assays and multiplexed biomarker detection. In 2010, the National Institute of Health (NIH) awarded Maven a $1.96 million grant to commercialize the technology.